10q10k10q10k.net
Evolent Health, Inc.

Evolent Health, Inc.EVHEarnings & Financial Report

NYSE · managed care

Magellan Health Inc., is an American for-profit managed health care company and subsidiary of Centene that focuses on special populations and other specialty areas of healthcare. Magellan's customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators. It ranked 390 on the Fortune 500 in 2021.

NextMar 19, 2026

EVH Q3 2025 Key Financial Metrics

Revenue

$479.5M

Gross Profit

$99.8M

Operating Profit

$886.0K

Net Profit

$-20.9M

Gross Margin

20.8%

Operating Margin

0.2%

Net Margin

-4.4%

YoY Growth

-22.8%

EPS

$-0.24

Financial Flow

Evolent Health, Inc. Q3 2025 Financial Summary

Evolent Health, Inc. reported revenue of $479.5M for Q3 2025, with a net profit of $-20.9M (-4.4% margin). Cost of goods sold was $379.8M, operating expenses totaled $98.9M.

Key Financial Metrics

Total Revenue$479.5M
Net Profit$-20.9M
Gross Margin20.8%
Operating Margin0.2%
Report PeriodQ3 2025

Evolent Health, Inc. Annual Revenue by Year

Evolent Health, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $2.6B).

YearAnnual Revenue
2024$2.6B
2023$2.0B
2022$1.4B

Income Statement

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Revenue$556.1M$639.7M$647.1M$621.4M$646.5M$483.6M$444.3M$479.5M
YoY Growth45.4%49.6%37.9%21.6%16.3%-24.4%-31.3%-22.8%

Balance Sheet

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Assets$2.68B$2.64B$2.48B$2.50B$2.54B$2.65B$2.46B$2.45B
Liabilities$1.43B$1.41B$1.24B$1.28B$1.35B$1.52B$1.34B$1.61B
Equity$1.07B$1.05B$1.05B$1.04B$1.00B$935.5M$896.0M$842.2M

Cash Flow

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Operating CF$89.4M$4.9M$21.4M$18.7M$-26.2M$4.6M$-30.3M$15.8M